Publication of the Final Report of the Scientific Advisory Committee on Health Products Containing Cannabis
On August 2nd, the SAC-HPCC released their final report and recommendations for Health Canada’s consideration on the safety, efficacy and quality of cannabidiol (CBD) when used for therapeutic purposes. The mandate was to provide independent scientific and clinical advice to support Health Canada’s consideration of appropriate safety, efficacy and quality standards for health products containing cannabis. Read More
